coopercos.com - COO Total Company Value-to-Revenue Ratio

The Cooper Companies, Inc. (COO) - corporate logo

The competent management of The Cooper Companies (COO) ensures margin growth and the transparent development of women's health. The EV/Sales ratio clearly demonstrates the market value of the business relative to revenue, where 3271.55 serves as the current metric level. Manufacturing plants in the US and UK guarantee stability. A global oligopoly and advanced lens materials provide a reliable defense against price competition.

CooperVision (COO) EV/Sales Multiple: for the period 11/23/2025 - 11/20/2026

Financial and market metric breakdowns for CooperVision (COO)

- share price and consensus valuation forecast:
Fundamental company valuation:COO, coopercos.com
Flagship merchandise of The Cooper Companies, Inc.

The Cooper Companies (COO) bet on high-tech solutions in reproductive medicine and myopia control generates high added value for the business. By analyzing the EV/Revenue multiple trend, an investor can view market capitalization and net debt relative to sales volume, which eliminates the impact of leverage on the valuation. This indicator reflects long-term confidence in the effectiveness of the R&D cycle and determines the current margin of safety for the assets.

Competitor analysis

BSX (Boston Scientific) - Company Value to Revenue Ratio|EW: EV/Sales Multiple|RMD - Total Company Value-to-Revenue Ratio|PODD (Insulet Inc.) - EV/Sales Multiple|Company Value to Revenue Zimmer Biomet Corp (ZBH)|EV/Sales Multiple ALGN|Company Value to Revenue Globus Medical, Inc. GMED|EV/Sales Multiple TMDX (transmedics.com)|EV/Sales Multiple Alphatec Holdings ATEC|AORT - Enterprise Value-to-Revenue Ratio|ENOV: Enterprise Value-to-Revenue Ratio|IART (Integra LifeSciences) - Company Value to Revenue|Establishment Labs - Business Value to Revenue|BBNX (iLet Bionic Pancreas) - EV/Sales Multiple|Enterprise Value-to-Revenue Multiple IRADIMED Corp IRMD|Enterprise Value-to-Revenue Ratio Embecta Corp (EMBC)|Tandem Diabetes Care (TNDM) - Enterprise Value-to-Sales Ratio|Axogen Surgical - Company Value to Revenue|EV/Sales Multiple SI-BONE, Inc. SIBN|Orthofix Medical - EV/Sales Multiple|Enterprise Value to Sales Volume BVS|OrthoPediatrics (KIDS) - Enterprise Value-to-Revenue Ratio|Enterprise Value to Sales Volume TMCI (Treace Corp)|Enterprise Value-to-Revenue Ratio blade.com|Company Value to Revenue Carlsmed Inc (CARL)|EV/Sales Multiple RXST|CLPT - Enterprise Value-to-Revenue Multiple|Enterprise Value-to-Revenue Ratio Stereotaxis, Inc. STXS|STIM: Company Value to Revenue Ratio|SGHT: Company Value to Revenue|Orchestra BioMed Inc. - Enterprise Value-to-Revenue Coefficient|ANIK: EV/Sales Multiple|NSPR - Total Company Value-to-Revenue Ratio|ZJYL (Jin Medical) - EV/Sales Multiple|Vivani Medical (VANI) - Total Company Value-to-Revenue Ratio|EV/Sales Multiple XTNT|EV/Sales Multiple n1mtc.com (NMTC)|Modular Medical Inc - Company Value to Revenue|Myomo, Inc (MYO) - Enterprise Value-to-Revenue Multiple|COCH: Company Value to Revenue|Total Company Value-to-Revenue Ratio Vivos Therapeutics VVOS|enVVeno Medical Corp. (NVNO) - Enterprise Value-to-Revenue Ratio|Sintx Technologies - Business Value to Revenue|Enterprise Value-to-Revenue Ratio Tenon Medical Inc.|LFWD: Business Value to Revenue|EV/Sales Multiple AMIX|Enterprise Value-to-Revenue Coefficient IVF|Enterprise Value-to-Revenue Ratio Bone Biologics BBLG|Total Company Value-to-Revenue Ratio axonics.com (AXNX)|BIOL - Enterprise Value-to-Revenue Ratio|Dynatronics (DYNT) - Company Value to Revenue|Paragon 28, Inc. (FNA) - Enterprise Value-to-Revenue Ratio|INVO - Total Company Value-to-Revenue Ratio